| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |